Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
The Journal of Antimicrobial Chemotherapy|May 16, 2014
Pharmacodynamic activity of ertapenem versus genotypically characterized extended-spectrum β-lactamase (ESBL)-, KPC- or NDM-producing Escherichia coli with reduced susceptibility or resistance to ertapenem using an in vitro modelGeorge G Zhanel, Andrew Denisuik, Shivangi Vashisht, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 2011
Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007-2009 studyHeather J Adam, Melanie DeCorby, Robert Rennie, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 2011
In vitro activity of ceftobiprole against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens: results of the CANWARD 2007-2009 studyAndrew Walkty, Heather J Adam, Michel Laverdière, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 2021
In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007-18)George G Zhanel, Heather J Adam, Melanie Baxter, et al.
Antimicrobial Agents and Chemotherapy|September 10, 2009
In vitro activity of nemonoxacin, a novel nonfluorinated quinolone, against 2,440 clinical isolatesHeather J Adam, Nancy M Laing, C Richard King, et al.
Jac-Antimicrobial Resistance|December 5, 2022
Antimicrobial resistance patterns of bacterial pathogens recovered from the urine of patients at Canadian hospitals from 2009 to 2020Andrew Walkty, James A Karlowsky, Philippe Lagace-Wiens, et al.
The Journal of Antimicrobial Chemotherapy|August 30, 2005
Are fluoroquinolone-susceptible isolates of Streptococcus pneumoniae really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003Kristen N Schurek, Heather J Adam, Christine G Siemens, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2011
Prevalence of antimicrobial resistance among clinical isolates of Bacteroides fragilis group in Canada in 2010-2011: CANWARD surveillance studyJames A Karlowsky, Andrew J Walkty, Heather J Adam, et al.
The Journal of Antimicrobial Chemotherapy|August 24, 2013
Evolution and molecular characterization of macrolide-resistant Streptococcus pneumoniae in Canada between 1998 and 2008Aleksandra K Wierzbowski, James A Karlowsky, Heather J Adam, et al.
The Journal of Antimicrobial Chemotherapy|January 19, 2026
Enterococcus faecium harbouring vanA, optrA and cfr(D) on a linear plasmid in Canada: a CANWARD surveillance caseMelissa McCracken, Nicole Lerminiaux, Heather J Adam, et al.
Pageof 10